Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Roswell Park Cancer Institute
Uppsala University
University of Washington
Minia University
University of Washington
University of Chicago
Rezolute
Institut Paoli-Calmettes
Alliance for Clinical Trials in Oncology
UMC Utrecht
European Institute of Oncology
University of Chicago
AC Camargo Cancer Center
Dana-Farber Cancer Institute
Fudan University
Changhai Hospital
University of California, San Francisco
Guangxi Medical University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Singapore General Hospital
HaEmek Medical Center, Israel
Yale University
Peking Union Medical College Hospital
Dana-Farber Cancer Institute
University of Iowa
Federation Francophone de Cancerologie Digestive
Asan Medical Center
Vanderbilt-Ingram Cancer Center
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Assistance Publique - Hôpitaux de Paris
Ochsner Health System
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt-Ingram Cancer Center